ARCHIVES

FDA Oncology Division Director Says Goal to Make Review Process “Predictable”

This article is from The Cancer Letter archive.

Vol. 22 No. 31 | August 2, 1996

Download PDF Visit The Full Archive

Related Articles

Stone(y) Silence Didn’t Save His Job; Niamd’s Rall Rumored as Top Choice As New NIH Director

December 20, 1974

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013

For Research Projects In Cancer Therapy

March 1, 1996

Coalition On Smoking Or Health to Launch Effort at $5 Tax Increase

July 3, 1992

DCPC Concepts Approved For Tw Grants Support Contract

January 31, 1986

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

April 29, 1994